Literature DB >> 20012133

Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer.

J-Matthias von der Schulenburg1, Anne Prenzler, Willemien Schurer.   

Abstract

This paper provides an overview of cancer management, particularly with respect to colorectal cancer (CRC), in Germany. The information presented reflects findings from the peer-review literature and government documentation, as well as interviews with cancer and CRC specialists. Topics such as epidemiology, expenditure, CRC screening, pharmaceutical and non-pharmaceutical treatment are discussed in this paper. Furthermore, insights into the German reimbursement system with regard to cancer management as well as regulatory aspects are presented.

Entities:  

Mesh：

Year:  2010        PMID： 20012133     DOI： 10.1007/s10198-009-0194-x

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN： 1618-7598


  11 in total

1.  EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century.

Authors:  M P Coleman; G Gatta; A Verdecchia; J Estève; M Sant; H Storm; C Allemani; L Ciccolallo; M Santaquilani; F Berrino
Journal:  Ann Oncol       Date:  2003       Impact factor: 32.976

2.  Costs of treatment of colorectal cancer in different settings in Germany.

Authors:  Klaus Hieke; Ulrich R Kleeberg; Martina Stauch; Axel Grothey
Journal:  Eur J Health Econ       Date:  2004-10

3.  Estimates of cancer incidence and mortality in Europe in 1995.

Authors:  F Bray; R Sankila; J Ferlay; D M Parkin
Journal:  Eur J Cancer       Date:  2002-01       Impact factor: 9.162

4.  Surgery of colorectal cancer: surgical morbidity and five- and ten-year results in 2400 patients--monoinstitutional experience.

Authors:  Ludger Staib; Karl Heinz Link; Annette Blatz; Hans Günther Beger
Journal:  World J Surg       Date:  2001-11-26       Impact factor: 3.352

5.  Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study.

Authors:  Franco Berrino; Roberta De Angelis; Milena Sant; Stefano Rosso; Magdalena Bielska-Lasota; Magdalena B Lasota; Jan W Coebergh; Mariano Santaquilani
Journal:  Lancet Oncol       Date:  2007-09       Impact factor: 41.316

6.  Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.

Authors:  Arduino Verdecchia; Silvia Francisci; Hermann Brenner; Gemma Gatta; Andrea Micheli; Lucia Mangone; Ian Kunkler
Journal:  Lancet Oncol       Date:  2007-09       Impact factor: 41.316

7.  Cost-saving analysis of screening colonoscopy in Germany.

Authors:  A Sieg; H Brenner
Journal:  Z Gastroenterol       Date:  2007-09       Impact factor: 2.000

8.  [Methodological standards for cost-of-illness studies using breast cancer, prostate cancer and colon cancer as an example].

Authors:  Oliver Damm; Jan-Marc Hodek; Wolfgang Greiner
Journal:  Z Evid Fortbild Qual Gesundhwes       Date:  2009

9.  Estimates of the cancer incidence and mortality in Europe in 2006.

Authors:  J Ferlay; P Autier; M Boniol; M Heanue; M Colombet; P Boyle
Journal:  Ann Oncol       Date:  2007-02-07       Impact factor: 32.976

10.  Appropriateness of colonoscopy in the era of colorectal cancer screening: a prospective, multicenter study in a private-practice setting (Berlin Colonoscopy Project 1, BECOP 1).

Authors:  Andreas Adler; Stephanie Roll; Bernhard Marowski; Rolf Drossel; Hans-Ulrich Rehs; Stefan N Willich; Jutta Riese; Bertram Wiedenmann; Thomas Rösch
Journal:  Dis Colon Rectum       Date:  2007-10       Impact factor: 4.585
View more
  8 in total

Review 1.  [International status colorectal cancer screening and quality assurance of screening-colonoscopy].

Authors:  Nikolaus Patera; Claudia Wild
Journal:  Wien Med Wochenschr       Date:  2013-09-05

2.  The dynamics of colorectal cancer management in 17 countries.

Authors:  Panos Kanavos; Willemien Schurer
Journal:  Eur J Health Econ       Date:  2010-01

3.  Cross-national comparison of medical costs shared by payers and patients: a study of postmenopausal women with early-stage breast cancer based on assumption case scenarios and reimbursement fees.

Authors:  Shota Hamada; Shiro Hinotsu; Hiroshi Ishiguro; Masakazu Toi; Koji Kawakami
Journal:  Breast Care (Basel)       Date:  2013-08       Impact factor: 2.860

4.  Capsule colonoscopy increases uptake of colorectal cancer screening.

Authors:  Stefan Groth; Horst Krause; Rainer Behrendt; Helge Hill; Michael Börner; Murat Bastürk; Nora Plathner; Friedrich Schütte; Ulrich Gauger; Jürgen Ferdinand Riemann; Lutz Altenhofen; Thomas Rösch
Journal:  BMC Gastroenterol       Date:  2012-06-26       Impact factor: 3.067

5.  Evaluating the quality of colorectal cancer care across the interface of healthcare sectors.

Authors:  Sabine Ludt; Elisabeth Urban; Jörg Eckardt; Stefanie Wache; Björn Broge; Petra Kaufmann-Kolle; Günther Heller; Antje Miksch; Katharina Glassen; Katja Hermann; Regine Bölter; Dominik Ose; Stephen M Campbell; Michel Wensing; Joachim Szecsenyi
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

6.  Incidence and mortality trends of gastric and colorectal cancers in Croatia, 1988-2008.

Authors:  Iva Kirac; Mario Sekerija; Iva Simunović; Lina Zgaga; Danko Velimir Vrdoljak; Dujo Kovacević; Tomislav Kulis; Ariana Znaor
Journal:  Croat Med J       Date:  2012-04       Impact factor: 1.351

Review 7.  A systematic review of cost-sharing strategies used within publicly-funded drug plans in member countries of the organisation for economic co-operation and development.

Authors:  Lianne Barnieh; Fiona Clement; Anthony Harris; Marja Blom; Cam Donaldson; Scott Klarenbach; Don Husereau; Diane Lorenzetti; Braden Manns
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

8.  Annual cost of hospitalization, inpatient rehabilitation, and sick leave for head and neck cancers in Germany.

Authors:  Jens P Klussmann; Peter K Schädlich; Xiaoyu Chen; Vanessa Rémy
Journal:  Clinicoecon Outcomes Res       Date:  2013-05-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.